Literature DB >> 18832946

Follicle-stimulating hormone treatment of male infertility.

Carlo Foresta1, Riccardo Selice, Andrea Garolla, Alberto Ferlin.   

Abstract

PURPOSE OF REVIEW: Treatment with gonadotrophins is very effective in patients affected by hypogonadotrophic hypogonadism. The success of follicle-stimulating hormone (FSH) treatment in these men has brought the utilization of the same therapy in infertile oligozoospermic patients, aimed at obtaining a quantitative increase in sperm count. RECENT
FINDINGS: FSH plays a crucial role in human reproduction. This physiological role in spermatogenesis has induced various attempts to treat idiopathic oligozoospermic men with FSH, often inducing the restoration of normal spermatogenesis and spontaneous pregnancy. However, the results obtained so far are still controversial. In this research, attention is focused on the possible criteria able to predict a seminal response to the specific hormonal treatment. Moreover, we have correlated different polymorphisms of FSH receptor gene with the outcome of FSH treatment. In this article, the literature is reviewed, and the authors' experience on using FSH treatment in oligozoospermic patients is discussed.
SUMMARY: FSH treatment may represent a valid tool for infertile men. However, it should be performed on selected patients utilizing some predictive parameters able to identify a priori responder patients with high probability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832946     DOI: 10.1097/MOU.0b013e328313647d

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  9 in total

Review 1.  Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications.

Authors:  Brian J Arey; Francisco J López
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 2.  Novel pathways in gonadotropin receptor signaling and biased agonism.

Authors:  Alfredo Ulloa-Aguirre; Pascale Crépieux; Anne Poupon; Marie-Christine Maurel; Eric Reiter
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Lower sperm DNA fragmentation after r-FSH administration in functional hypogonadotropic hypogonadism.

Authors:  Giovanni Ruvolo; Maria Carmela Roccheri; Anna Maria Brucculeri; Salvatore Longobardi; Ettore Cittadini; Liana Bosco
Journal:  J Assist Reprod Genet       Date:  2013-02-24       Impact factor: 3.412

Review 4.  Pharmacogenetics of follicle-stimulating hormone action.

Authors:  Maris Laan; Marina Grigorova; Ilpo T Huhtaniemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

5.  Inducible male infertility by targeted cell ablation in zebrafish testis.

Authors:  Chia-Chun Hsu; Min-Fon Hou; Jiann-Ruey Hong; Jen-Leih Wu; Guor Mour Her
Journal:  Mar Biotechnol (NY)       Date:  2009-11-24       Impact factor: 3.619

6.  Increased Prevalance of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men.

Authors:  Marina Grigorova; Margus Punab; Olev Poolamets; Piret Kelgo; Kristo Ausmees; Paul Korrovits; Vladimir Vihljajev; Maris Laan
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

7.  THE FREQUENCY OF FOLLICLE-STIMULATING HORMONE RECEPTOR 2039A>G GENE POLYMORPHISM AND THE RISK OF MALE INFERTILITY IN ALBANIAN POPULATION.

Authors:  Elezaj Shkelzen; Frane Paić; Feodora Stipoljev; Zafer Gashi; Afrim Zeqiraj; Albert Lila; Tamara Nikuševa Martić
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780

Review 8.  An overview of FSH-FSHR biology and explaining the existing conundrums.

Authors:  Deepa Bhartiya; Hiren Patel
Journal:  J Ovarian Res       Date:  2021-10-30       Impact factor: 4.234

9.  Evaluation of the Spermatogenic Activity of Polyherbal Formulation in Oligospermic Males.

Authors:  Syed Ammar Hussain; Ahsan Hameed; Furqan Nasir; Yang Wu; Hafiz Ansar Rasul Suleria; Yuanda Song
Journal:  Biomed Res Int       Date:  2018-07-25       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.